Researchers have used an artificial intelligence (AI) technique to successfully treat a patient with advanced cancer, completely halting the disease progression. In a study, a patient suffering from metastatic prostate cancer was given a novel drug combination. The team then used the AI to continuously identify the optimal doses of each drug, allowing the patient to resume a normal lifestyle.
“Dynamic dosing in cancer therapy is not commonly used. In fact, drug dosing changes in oncology are typically performed only to reduce toxicity,” said lead author Dean Ho, Professor at the NUS.